☆ 4.7 Article

A Comparative Study of the Plasma Chemokine Profile in COVID-19 Patients Infected with Different SARS-CoV-2 Variants

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Related references

Note: Only part of the references are listed.

Article Infectious Diseases

Decreased severity of disease during the first global omicron variant covid-19 outbreak in a large hospital in tshwane, south africa

F. Abdullah et al.

Summary: This study analyzed the clinical data of COVID-19 patients admitted to a hospital in Tshwane during the Omicron wave, and found that the severity of the disease was decreased compared to previous waves, with lower death rates and ICU admissions.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2022)

Add to Collection

Review Biochemistry & Molecular Biology

What Is Currently Known about the Role of CXCL10 in SARS-CoV-2 Infection?

Monika Gudowska-Sawczuk et al.

Summary: Dysregulation of the immune response is crucial in the progression of SARS-CoV-2 infection. CXCL10, a chemokine, has been suggested to be associated with inflammatory diseases and may play a role in the development of COVID-19. Elevated levels of CXCL10 have been found in COVID-19 patients and are associated with disease severity and progression.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Add to Collection

Article Medicine, General & Internal

Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study

Cristina Menni et al.

Summary: This study investigated the differences in symptom prevalence, risk of hospital admission, and symptom duration between omicron and delta variants of the SARS-CoV-2 virus. The study found that loss of smell was less common in omicron infections, sore throat was more common, and the rate of hospital admission was lower.

LANCET (2022)

Add to Collection

Review Physiology

Mechanisms of Lung Injury Induced by SARS-CoV-2 Infection

Samsara Upadhya et al.

Summary: This article provides a comprehensive overview of the multifaceted mechanisms of lung injury caused by SARS-CoV-2 infection, including direct viral infection, chemokine/cytokine-mediated damage, and immune cell-mediated lung injury. The article also discusses the latest progress in antiviral therapeutics and the development of anti-inflammatory or immunomodulatory therapeutic approaches.

PHYSIOLOGY (2022)

Add to Collection

Article Infectious Diseases

Clinical outcomes in patients infected with different SARS-CoV-2 variants at one hospital during three phases of the COVID-19 epidemic in Marseille, France

Van-Thuan Hoang et al.

Summary: This study compared the demographics, clinical characteristics, and severity of patients infected with different SARS-CoV-2 variants during various phases of the COVID-19 epidemic. Results showed that there were no major differences in age, gender, prevalence of chronic diseases, and clinical symptoms between variants in different phases, but certain variants were associated with more severe outcomes. Infections during the second phase had a higher death rate compared to the first and third phases.

INFECTION GENETICS AND EVOLUTION (2021)

Add to Collection

News Item Medicine, General & Internal

Autopsies Reveal Lung Damage Patterns From COVID-19

Melissa Suran

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Add to Collection

Article Immunology

SARS-CoV-2 genomic characterization and clinical manifestation of the COVID-19 outbreak in Uruguay

Victoria Elizondo et al.

Summary: Uruguay has been successful in containing the COVID-19 outbreak, with at least 23 independent introductions of the virus resulting in five major transmission clusters, primarily originating from other South American countries and seeding the virus weeks before border closure and partial lockdown. The dominant viral strains in the study were the S and G clades, accounting for over 90% of the strains. Lethal outcomes of SARS-CoV-2 infection were significantly correlated with arterial hypertension, kidney failure, and ICU admission, rather than a specific mutation in structural or non-structural proteins.

EMERGING MICROBES & INFECTIONS (2021)

Add to Collection

Article Immunology

Interleukin-8 as a Biomarker for Disease Prognosis of Coronavirus Disease-2019 Patients

Lili Li et al.

Summary: The study identified IL-8 as a biomarker to predict disease severity and prognosis of COVID-19 patients, showing that IL-8 is more distinct for mild cases compared to IL-6.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Chemokines and chemokine receptors during COVID-19 infection

Bariaa A. Khalil et al.

Summary: Chemokines play a crucial role in the immune response by clearing pathogens, but their excessive release can lead to hyperinflammation and severe complications. In COVID-19, chemokines may directly cause acute respiratory distress syndrome, increasing the risk of death. Understanding the role of chemokines in COVID-19 pathogenesis is important for developing potential therapeutic targets.

COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Cytokines and Chemokines in SARS-CoV-2 Infections-Therapeutic Strategies Targeting Cytokine Storm

Alexandra Pum et al.

Summary: The presence and involvement of specific chemokines are crucial for the development and progression of COVID-19, leading to severe respiratory distress syndrome and pneumonia with fatal consequences. Cytokine storm and the resulting cytokine release syndrome are pathophysiological hallmarks in severe cases of COVID-19 infections, where chemokines and other cytokines are highly upregulated and cause harmful effects. There are therapeutics in clinical development targeting these factors to potentially treat COVID-19 infections.

BIOMOLECULES (2021)

Add to Collection

Article Immunology

Longitudinal profiling of respiratory and systemic immune responses reveals myeloid cell-driven lung inflammation in severe COVID-19

Peter A. Szabo et al.

Summary: This study investigated the immune responses in the respiratory tract and blood of severe COVID-19 patients, revealing that T cells in the airways showed protective profiles while myeloid cells exhibited hyperinflammatory signatures. These findings provide important insights for understanding and treating COVID-19 lung pathology.

IMMUNITY (2021)

Add to Collection

Article Infectious Diseases

Different mutations in SARS-CoV-2 associate with severe and mild outcome

Adam Nagy et al.

Summary: The study found a correlation between protein-level mutations in the SARS-CoV-2 virus and clinical outcomes, with some mutations associated with severe disease.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2021)

Add to Collection

Article Cell Biology

Lung epithelial and endothelial damage, loss of tissue repair, inhibition of fibrinolysis, and cellular senescence in fatal COVID-19

Felice D'Agnillo et al.

Summary: This study identified significant pulmonary pathological features in fatal COVID-19 cases, including progressive diffuse alveolar damage, excessive thrombosis, and delayed pulmonary tissue and vascular remodeling. Acute damage at the alveolar-capillary barrier was characterized by loss of surfactant protein expression and injury to various types of cells, such as alveolar epithelial cells and endothelial cells. These findings provide insights into potential therapeutic targets for treating SARS-CoV-2 infection-induced respiratory distress.

SCIENCE TRANSLATIONAL MEDICINE (2021)

Add to Collection

Article Multidisciplinary Sciences

SARS-CoV-2 D614G spike mutation increases entry efficiency with enhanced ACE2-binding affinity

Seiya Ozono et al.

Summary: The naturally occurring mutations of SARS-CoV-2 spike protein can affect cell entry, with the D614G mutation resulting in increased cell entry and maintaining susceptibility to neutralization by antisera against prototypic viruses. Further global surveillance is needed to understand the transmissibility of SARS-CoV-2 among humans.

NATURE COMMUNICATIONS (2021)

Add to Collection

Review Medicine, General & Internal

Severe covid-19 pneumonia: pathogenesis and clinical management

Amy H. Attaway et al.

Summary: Severe covid-19 pneumonia presents challenges for medical research and treatment, with specific risk factors and clinical features identified. Approaches involving high flow nasal cannula, ventilation strategies, and medication choices are important for managing severe cases. Comprehensive interdisciplinary methods are essential for the recovery of critically ill covid-19 patients.

BMJ-BRITISH MEDICAL JOURNAL (2021)

Add to Collection

Article Public, Environmental & Occupational Health

Investigation of a SARS-CoV-2 B.1.1.529 (Omicron) Variant Cluster — Nebraska, November–December 2021

Lauren Jansen et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)

Add to Collection

Article Multidisciplinary Sciences

The spatial landscape of lung pathology during COVID-19 progression

Andre F. Rendeiro et al.

Summary: Recent studies using high-parameter imaging mass cytometry have provided insights into the cellular composition and spatial architecture of acute lung injury in humans, including injuries derived from SARS-CoV-2 infection. It was found that SARS-CoV-2 predominantly infects alveolar epithelial cells and induces a localized hyperinflammatory cell state associated with lung damage. As COVID-19 progresses, there is increased macrophage extravasation, along with increased numbers of mesenchymal cells and fibroblasts, possibly indicating attempts to repair the damaged lung tissue. The data generated help in developing a biologically interpretable landscape of lung pathology at both macroscopic and single-cell levels, providing a basis for understanding COVID-19 and lung pathology.

NATURE (2021)

Add to Collection

Article Medicine, Research & Experimental

Could SARS-CoV-2 blocking of ACE2 in endothelial cells result in upregulation of CX3CL1, promoting thrombosis in COVID-19 patients?

Selma Rivas-Fuentes et al.

Summary: SARS-CoV-2 is the causal agent of COVID-19, which has resulted in over 2.5 million deaths globally with no effective treatment. Severe symptoms of COVID-19, including hyperinflammatory syndrome and thrombosis, highlight the need to further understand the molecular mechanisms involved in the disease's pathophysiology. Hypotheses about molecules like CX3CL1 potentially playing a role in COVID-19-associated thrombosis encourage basic and clinical studies to find effective treatments.

MEDICAL HYPOTHESES (2021)

Add to Collection

Review Microbiology

SARS-CoV-2 variants, spike mutations and immune escape

William T. Harvey et al.

Summary: The evolution of SARS-CoV-2 has been characterized by the emergence of mutations and variants that impact virus characteristics. Manufacturers are preparing for possible updates to vaccines in response to changes in the virus population, and it is crucial to monitor genetic and antigenic changes alongside experiments to understand the impacts of mutations.

NATURE REVIEWS MICROBIOLOGY (2021)

Add to Collection

Article Virology

The Pro-Inflammatory Chemokines CXCL9, CXCL10 and CXCL11 Are Upregulated Following SARS-CoV-2 Infection in an AKT-Dependent Manner

Victoria Callahan et al.

Summary: The study shows that SARS-CoV-2 infection induces an inflammatory state in human lung epithelial cells with elevated levels of pro-inflammatory chemokines and cytokines. Inhibition of the AKT pathway may reduce the induction of these chemokines, potentially providing specific targets for mitigating SARS-CoV-2 pathogenesis associated with hyperinflammation.

VIRUSES-BASEL (2021)

Add to Collection

Article Medicine, Research & Experimental

Characterization of SARS-CoV-2 and host entry factors distribution in a COVID-19 autopsy series

Xiao-Ming Wang et al.

Summary: This study characterizes the tissue distribution of SARS-CoV-2 viral infection and replication as well as the expression of host cell entry factors in postmortem samples from six patients with COVID-19. The findings illustrate the impact of dispersed SARS-CoV-2 infection in diverse organ systems, providing avenues for systematic therapeutic approaches.

COMMUNICATIONS MEDICINE (2021)

Add to Collection

Editorial Material Microbiology

SARS-CoV-2 variants: Relevance for symptom granularity, epidemiology, immunity (herd, vaccines), virus origin and containment?

Antoine Danchin et al.

ENVIRONMENTAL MICROBIOLOGY (2020)

Add to Collection

Article Infectious Diseases

Could the D614G substitution in the SARS-CoV-2 spike (S) protein be associated with higher COVID-19 mortality?

Muthukrishnan Eaaswarkhanth et al.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)

Add to Collection

Article Critical Care Medicine

Characterization of the Inflammatory Response to Severe COVID-19 Illness

Oliver J. McElvaney et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)

Add to Collection

Article Medicine, General & Internal

The Pathology of Severe COVID-19-Related Lung Damage Mechanistic and Therapeutic Implications

Felix K. F. Kommoss et al.

DEUTSCHES ARZTEBLATT INTERNATIONAL (2020)

Add to Collection

Article Immunology

ACE2, Much More Than Just a Receptor for SARS-COV-2

Lobelia Samavati et al.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2020)

Add to Collection

Article Immunology

Serum Cytokine and Chemokine Profile in Relation to the Severity of Coronavirus Disease 2019 in China

Ying Chi et al.

JOURNAL OF INFECTIOUS DISEASES (2020)

Add to Collection

Review Health Care Sciences & Services

Hazards of the Cytokine Storm and Cytokine-Targeted Therapy in Patients With COVID-19: Review

Miguel Quirch et al.

JOURNAL OF MEDICAL INTERNET RESEARCH (2020)

Add to Collection

Editorial Material Critical Care Medicine

Biological Mechanisms of COVID-19 Acute Respiratory Distress Syndrome

Michael A. Matthay et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)

Add to Collection

Article Immunology

Within-Host Diversity of SARS-CoV-2 in COVID-19 Patients With Variable Disease Severities

Hebah A. Al Khatib et al.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2020)

Add to Collection

Article Immunology

Heightened Circulating Interferon-Inducible Chemokines, and Activated Pro-Cytolytic Th1-Cell Phenotype Features Covid-19 Aggravation in the Second Week of Illness

Camilla Tincati et al.

FRONTIERS IN IMMUNOLOGY (2020)

Add to Collection

Letter Biochemistry & Molecular Biology

Scoring cytokine storm by the levels of MCP-3 and IL-8 accurately distinguished COVID-19 patients with high mortality

Liting Chen et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)

Add to Collection

Article Biochemistry & Molecular Biology

A guide to chemokines and their receptors

Catherine E. Hughes et al.

FEBS JOURNAL (2018)

Add to Collection

Article Immunology

Th17 cells regulate the production of CXCL1 in breast cancer

Kai Ma et al.

INTERNATIONAL IMMUNOPHARMACOLOGY (2018)

Add to Collection

Article Critical Care Medicine

MACROPHAGE-DERIVED CHEMOKINE (CCL22) IS A NOVEL MEDIATOR OF LUNG INFLAMMATION FOLLOWING HEMORRHAGE AND RESUSCITATION

Jillian R. Richter et al.

SHOCK (2014)

Add to Collection

Article Medicine, Research & Experimental

Elevation of macrophage-derived chemokine in eosinophilic pneumonia : a role of alveolar macrophages

Kazuyoshi Manabe et al.

JOURNAL OF MEDICAL INVESTIGATION (2005)

Add to Collection

Review Biochemistry & Molecular Biology

Macrophage inflammatory protein-1

P Menten et al.

CYTOKINE & GROWTH FACTOR REVIEWS (2002)

Add to Collection

© Peeref 2019-2024. All rights reserved.